Saturday, December 27, 2014 Last update: 8:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

The Best of U.S. Company Tech News - Updated Daily

Thursday, October 27, 2011

  • CDI Corp. Reports 2011 Third Quarter Results --- PHILADELPHIA, Oct. 27, 2011
    Posted at 3:10 AM
    CDI Corp. (NYSE: CDI) (the "Company") today reported financial results for the third quarter ended September 30, 2011. The Company also announced a quarterly cash dividend of $0.13 per share which will be paid on November 23, 2011 to all shareholders of record as of November 10, 2011. 2011 Third Quarter Key Points -- Revenue of $272.5 million, representing growth of 9.3% compared to the prior-year third quarter and ... read more
  • Posted at 3:10 AM
    Numerex Corp (NASDAQ: NMRX), a leading provider of business services, technology, and products for the worldwide machine-to-machine (M2M) market, today announced financial results for its third quarter ended September 30, 2011. "Numerex delivered another solid performance in the third quarter with 22% growth in its M2M subscription base and 15% growth in recurring revenues compared to the third quarter of last year. We finished the quarter with over 1.3 million subscriptions that now generate nearly $10 million in quarterly recurring revenues," ... read more
  • Posted at 3:09 AM
  • Posted at 3:05 AM
    ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the third quarter ended September 30, 2011. In the third quarter of 2011, we: -- Achieved a record $143 million in net product sales, representing 21 percent growth over the third quarter of 2010; -- Recorded $65 million in net sales of Cinryze for the third quarter and $184 ... read more
  • Posted at 3:03 AM
    GrafTech International Ltd. (NYSE:GTI) today announced financial results for the third quarter ended September 30, 2011. 2011 Third Quarter Highlights Net sales increased 35 percent to $346 million from $255 ... read more
  • Posted at 3:02 AM
    BERKELEY, CA -- (Marketwire) -- 10/27/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September 30, 2011, including $53.2 million in cash, cash equivalents and marketable securities at September 30, 2011. This amount does not include a total of $8.6 million, consisting of $6 million in previously announced payments from Dynavax's collaborations with AstraZeneca and GlaxoSmithKline to be made after the close of the quarter and proceeds of $2.6 million from the ... read more
  • Posted at 3:00 AM
    WILMINGTON, MA -- (Marketwire) -- 10/27/11 -- Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced sales of its Quantum Sniffer™ QS-H150 portable explosives trace detection devices to two new customers in Europe. Units have been sold for deployment in the protection of a major European bank and for use in training at an international explosives ordinance disposal (EOD) school. "The current economic and political environment in ... read more
  • Posted at 3:00 AM
    UTICA, NY -- (Marketwire) -- 10/27/11 -- CONMED Corporation (NASDAQ: CNMD) today announced financial results for the third quarter of 2011. Sales for the third quarter ended September 30, 2011 were $172.8 million compared to $172.2 million in the same quarter of 2010. GAAP diluted earnings per share were $0.29 compared to $0.31 in the third quarter of 2010. An income tax adjustment in the third quarter of 2010 caused GAAP EPS in that quarter to be higher by ... read more
  • Posted at 3:00 AM
    SAN DIEGO, CA -- (Marketwire) -- 10/27/11 -- Cubic Defense Applications, the defense systems business of Cubic Corporation (NYSE: CUB), has received a task order of $16.8 million for Instrumentable Multiple Integrated Laser Engagement System Tactical Vehicle System (IMILES TVS) kits from the U.S. Army's Program Executive Office for Simulation, Training and Instrumentation (PEO STRI). The order is under an indefinite delivery/indefinite quantity (ID/IQ) contract awarded last year. In August, PEO STRI issued a $13 million task order under ... read more
  • Posted at 3:00 AM
    Nu Skin Enterprises, Inc. (NYSE: NUS) is pleased to announce that it has executed a letter of intent to acquire LifeGen Technologies, LLC, a genomics company based in Madison, Wisconsin for $11,662,500. The letter of intent includes the acquisition of substantially all of the assets of LifeGen, including its tissue bank, proprietary gene expression database, patents and intellectual property related to gene research. In connection with the transaction, the company will also enter into consulting agreements with LifeGen co-founders, Richard ... read more
  • Garb Oil & Power Corp.: Open October Conference Call --- SALT LAKE CITY, Oct. 27, 2011
    Posted at 3:00 AM
    Garb Oil & Power Corporation (USOTC: GARB). Our next conference call is set for Tuesday November 1, 2011 at 4:15 pm Eastern Time. Many of you had questions, which the last conference call did not answer. We will attempt to answer as many of the questions that are posed during the conference call. The conference call will be an open question and answers. Every participant will be free to ask questions on topics of concern or interest. Please call in ... read more
  • Cardinal Health Reports First-Quarter Results --- DUBLIN, Ohio, Oct. 27, 2011
    Posted at 3:00 AM
    Cardinal Health today reported fiscal year 2012 first-quarter revenue of $26.8 billion and an 11 percent increase in non-GAAP diluted earnings per share (EPS) to $0.73. On a GAAP basis, diluted EPS from continuing operations declined 19 percent to $0.68, reflecting a prior-year gain of $0.21 from the sale of CareFusion stock. Strong revenue growth was driven by 10 percent revenue increases in both the Pharmaceutical and Medical segments. Results reflected 16 percent growth in non-GAAP operating earnings, led by ... read more
  • Posted at 3:00 AM
    Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), is introducing a novel CHOZN® GS-/- Zinc Finger Nuclease (ZFN)-modified Chinese Hamster Ovary (CHO) cell line. Designed for use in the production of biopharmaceuticals, the new CHOZN GS-/- cell line is the first commercially available glutamine synthetase (GS) knockout CHO cell line proven to shorten bioproduction times in early development, enabling customers to enhance their speed-to-market and increase cost efficiency. For more information, visit ... read more
  • Posted at 3:00 AM
    ViroPharma Incorporated (NASDAQ: VPHM) today announced that it has signed a definitive agreement to acquire DuoCort Pharma AB, a private company based in Helsingborg, Sweden focused on improving glucocorticoid replacement therapy. The acquisition of DuoCort Pharma AB will further expand ViroPharma's orphan disease commercial product pipeline. The company intends to discuss this acquisition on its third quarter financial results conference call this morning. The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for their ... read more
  • Posted at 3:00 AM
    United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2011. "We achieved over $200 million in revenues this quarter, which reflects the continued strength of our core business," remarked Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "I'm also pleased that our Board of Directors recently authorized a $300 million share repurchase program, which has already begun to return additional value to our shareholders." Total revenues for the quarter ended September 30, ... read more
  • Posted at 3:00 AM
    RESTON, Va., Oct. 27, 2011 /PRNewswire/ -- -- Net subscriber additions of 433,000 -- Consolidated operating revenues of $1.75 billion -- Consolidated operating income before depreciation and amortization (OIBDA) of $381 million -- Consolidated operating income of $212 million and consolidated net loss of $3 million NII Holdings, Inc. (NASDAQ: NIHD) ... read more
  • Posted at 3:00 AM
    EarthLink, Inc. (NASDAQ: ELNK) today announced financial results for its third quarter ended September 30, 2011. The company also announced that it is raising its full year 2011 Adjusted EBITDA and Operating Cash Flow guidance. Highlights for the third quarter include: -- Net income of $7.5 million or $0.07 per share -- Adjusted EBITDA (a non-GAAP measure) of $90.5 million -- Operating cash flow (a non-GAAP measure) of ... read more
  • Posted at 3:00 AM
    Global aerospace and defense (A&D) merger and acquisition (M&A) value experienced a sharp increase in the third quarter of 2011, bolstered by one blockbuster transaction worth $16.1 billion announced during the period. The mega deal, if completed, would be the largest acquisition in the history of the A&D sector, according to Mission Control, a quarterly analysis of M&A activity in the global A&D sector by PwC US. (Logo: http://photos.prnewswire.com/prnh/20100917/NY66894LOGO) Third quarter deal value increased to $19.6 billion, with eight deals ... read more
  • Posted at 3:00 AM
    Iconix Brand Group, Inc. (NASDAQ: ICON) ("Iconix" the "Company") announced today that it has signed a definitive agreement to acquire The Sharper Image® brand and intellectual property assets from Sharper Image Acquisition, LLC for approximately $65.6 million in cash. This acquisition will mark the Company's first entry into the rising consumer electronics sector. Sharper Image is a respected brand in the consumer electronics industry with over 85% brand recognition, and is best known for its innovative products. This will be a ... read more
  • Posted at 3:00 AM
    Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg, the generic version of Purdue Pharma's MS Contin(®), an opioid analgesic for moderate to severe pain management. Morphine Sulfate ER Tablets had U.S. sales of approximately $173 million for the 12 ... read more